Dr. Diego Esteban Marra, MD

Dr. Marra practices at U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas.

Dr. Marra's NPI, 1023174414, was assigned on December 29, 2006. Dr. Marra graduated from Harvard Medical School in 2001. Dr. Marra's Texas license number on file is M5353.

Dr. Marra's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza, at 1367 Dominion Plz, Tyler, TX 75703. The practice phone is (903) 534-6200.

Dr. Marra's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Dr. Marra to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marra practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Marra's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Marra is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Marra's licenses on file in 3 states: Texas, Florida and California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal and skin cyst among the conditions Dr. Marra treats.

CMS data shows 2,063 Medicare services from Dr. Marra across 21 procedure codes in 2024, for 491 Medicare patients. Medicare paid $548,951 for them. Every service was in an office.

CMS counts 491 Medicare patients who saw Dr. Marra in 2024. The largest group is 75 to 84, with 234 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Marra's median patient age at 75, with 38% women.

In 2024, Dr. Marra wrote 1,087 Medicare Part D claims for 492 patients. 100% of them were for generic drugs. CMS names the drug for 1,049 of them, across 7 drugs with 11 or more claims each, at $11,895 in total drug cost. In 2023, CMS named 897 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Marra for performance year 2024, reported individually. Dr. Marra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 153 procedures of skin biopsy by Dr. Marra, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Marra, published from 2007 to 2015. 2015 was the busiest year, with 3. The most frequent topics are Muscle, Smooth, Vascular, Anti-Inflammatory Agents, Non-Steroidal and Aspirin. Dr. Marra has published most often in Arch Dermatol. Dr. Marra's most frequent co-authors are Edgar Franklin Fincher, MD, PhD, Yadranko Ducic, MD and Sameep P. Kadakia, MD.

CMS Open Payments shows 121 general payments to Dr. Marra from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $471.

Dr. Marra graduated from Harvard Medical School in 2001.

Dr. Marra is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.